
Shukra Pharmaceuticals Ltd
₹40.13
(-5.00)%
Fri, 13 Feb 2026, 04:50 am
1 Day
0 (0%)
No Result Found
Summary
Market Cap
1849.60
Net Profit
9.58
P/B
15.17
Sector P/E
32.61
P/E
99.32
EV/EBITDA
56.04
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
12.78
ROCE (Industry)
15.36
RONW (Industry)
13.46
ROE
15.90
ROCE
21.76
Debt/Equity
0.06
EPS (TTM)
0.67
Dividend Yield
0.02
Book Value
0.25
Interest Cover
23.61
Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 50.96 | 50.96 | 50.96 | 50.96 | 50.96 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 |
| Public | 48.93 | 48.93 | 48.93 | 48.93 | 48.93 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 86.83 | 66.43 | 53.47 | 46.03 | 33.07 | 25.63 | 5.23 |
| Fibonacci | 66.43 | 58.64 | 53.82 | 46.03 | 38.24 | 33.42 | 25.63 |
| Camarilla | 46.12 | 44.25 | 42.38 | 46.03 | 38.64 | 36.77 | 34.90 |
Pivots Level: Classic
R3
+40.80
86.83
R2
+20.40
66.43
R1
+7.44
53.47
S1
-12.96
33.07
S2
-20.40
25.63
S3
-40.80
5.23
Moving Average
Period
Value
10-EMA
42.47
20-EMA
43.66
30-EMA
44.72
50-EMA
45.10
100-EMA
41.93
200-EMA
34.82
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 04 Feb 2026 | board-meetings | Quarterly Results | |
| 13 Nov 2025 | board-meetings | Quarterly Results | |
| 04 Oct 2025 | egm | ||
| 30 Aug 2025 | agm | ||
| 04 Jun 2025 | dividend | ₹0.01 Dividend /Share | 18 Sept 2025 |
| 29 Jan 2025 | split | 1:10 Splits of Equity Shares | 21 Mar 2025 |
| 15 Sept 2024 | agm | ||
| 30 Jul 2024 | egm | ||
| 29 May 2024 | dividend | ₹1.00 Dividend /Share | 24 Sept 2024 |
| 08 Apr 2024 | bonus | 3:1 Bonus Issue of Equity Shares | 20 Apr 2024 |
Peer Comparison

Shukra Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd

Cipla Ltd

Divis Laboratories Ltd
About Shukra Pharmaceuticals Ltd
Shukra Pharmaceuticals is engaged primarily in the business of manufacture and marketing of pharmaceutical products.
Industry
Pharmaceuticals - Indian - Formulations
Founded
1993
Headquarters
CEO
Dakshesh Shah
Employees
Contact
Website
http://www.shukrapharmaceuticals.com
info@shukrapharmaceuticals.com
Phone
91-079-66522247/27498515
Location
3 rd Floor Dev House, Opp WIAA Office Judges Bungalo, Ahmedabad, Gujarat, 380054
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800